Product Images Carbidopa, Levodopa And Entacapone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Carbidopa, Levodopa And Entacapone NDC 55648-782 by Wockhardt Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structure - lectaborion m figure 01

Structure - lectaborion m figure 01

Structure - lectaborion m figure 02

Structure - lectaborion m figure 02

Structure - lectaborion m figure 03

Structure - lectaborion m figure 03

Label - lectaborion m figure 04

Label - lectaborion m figure 04

This text provides information on the dosage and administration of Carbidopa, Levodopa, and Entacapone Tablets. It advises users to swallow the tablets whole and not crush, split, or chew them. The tablets should be stored at 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) in a tightly sealed container. The manufacturer of the tablets is Orion Corporation, Orion Pharma, in Finland, while the tablets are distributed in the USA by Wockhardt USALLC. A cautionary warning advises not to combine two lower strength products to achieve a higher strength product as it may lead to an overdose of entacapone. Each film-coated tablet contains Carbidopa USP. The text also provides the NDC number and size (100 tablets). Overall, this text provides useful information on the Carbidopa, Levodopa, and Entacapone Tablets for users.*

label - lectaborion m figure 05

label - lectaborion m figure 05

Carbidopa, Levodopa and Entacapone Tablets are designed to lessen the symptoms of Parkinson's disease by increasing levels of the natural substances dopamine and levodopa. The recommended dosage can be found in the package insert and the tablets should not be crushed, split, or chewed. These tablets should be stored in a tight container at a temperature range of 15°C to 30°C (59°F to 86°F). The tablets are manufactured by Orion Pharma in Finland and distributed by Wockhardt USA LLC in the USA. Each tablet of this product contains 31.25 mg of Carbidopa USP, 125 mg of Levodopa USP, and 200 mg of Entacapone. It is important not to combine two lower strength products to make a higher strength medication, to avoid possible overdose of Entacapone.*

label - lectaborion m figure 06

label - lectaborion m figure 06

Carbidopa, Levodopa And Entacapone Tablets is a prescription drug that is manufactured by QOrion Corporation and distributed by Wockhardt USA LLC. It contains Carbidopa and Levodopa along with Entacapone. The tablets are film-coated and should be swallowed whole. Crushing, splitting, or chewing them is not recommended. It is advised to keep the medicine at room temperature, i.e., 25°C (77°F), and away from children. Each tablet has 200mg of Entacapone, and combining two lower strength products is not advisable as it may lead to an overdose.*

Label - lectaborion m figure 07

Label - lectaborion m figure 07

This is a medication with the generic name Carbidopa, Levodopa And Entacapone Tablets, manufactured by Orion Corporation. It's recommended to swallow the tablet whole and not to crush, chew, or split it. The tablets should be kept in a tight container at room temperature. The medication comes in 100 tablets and is distributed by Wockhardt USALLC. The package insert recommends not combining two weaker strength products to achieve a higher strength product as it may lead to an overdose of Entacapone.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.